Parida S
Eur J Microbiol Immunol (Bp). 2013; 2(4):275-81.
PMID: 24265909
PMC: 3832067.
DOI: 10.1556/EuJMI.2.2012.4.5.
Wilson R, Kumar P, Parashar V, Vilcheze C, Veyron-Churlet R, Freundlich J
Nat Chem Biol. 2013; 9(8):499-506.
PMID: 23770708
PMC: 3720791.
DOI: 10.1038/nchembio.1277.
Vijayan V
Indian J Clin Biochem. 2012; 17(2):96-100.
PMID: 23105358
PMC: 3454123.
DOI: 10.1007/BF02867979.
Srivastava L, Khanna M, Goel A, Jain R
Indian J Clin Biochem. 2012; 12(Suppl 1):83-5.
PMID: 23100909
PMC: 3454308.
DOI: 10.1007/BF02873069.
Greenstein R, Su L, Brown S
PLoS One. 2012; 7(1):e29631.
PMID: 22235314
PMC: 3250462.
DOI: 10.1371/journal.pone.0029631.
Direct drug susceptibility testing of Mycobacterium tuberculosis for rapid detection of multidrug resistance using the Bactec MGIT 960 system: a multicenter study.
Siddiqi S, Ahmed A, Asif S, Behera D, Javaid M, Jani J
J Clin Microbiol. 2011; 50(2):435-40.
PMID: 22162558
PMC: 3264138.
DOI: 10.1128/JCM.05188-11.
Rifampin-isoniazid oligonucleotide typing: an alternative format for rapid detection of multidrug-resistant Mycobacterium tuberculosis.
Hernandez-Neuta I, Varela A, Martin A, Groll A, Jureen P, Lopez B
J Clin Microbiol. 2010; 48(12):4386-91.
PMID: 20881173
PMC: 3008445.
DOI: 10.1128/JCM.00448-10.
Testing susceptibility of multidrug-resistant Mycobacterium tuberculosis to second-line drugs by use of blood agar.
Satana D, Coban A, Uzun M
J Clin Microbiol. 2010; 48(11):4291-3.
PMID: 20826642
PMC: 3020831.
DOI: 10.1128/JCM.00688-10.
Rates and mechanisms of resistance development in Mycobacterium tuberculosis to a novel diarylquinoline ATP synthase inhibitor.
Huitric E, Verhasselt P, Koul A, Andries K, Hoffner S, Andersson D
Antimicrob Agents Chemother. 2009; 54(3):1022-8.
PMID: 20038615
PMC: 2825986.
DOI: 10.1128/AAC.01611-09.
Tuberculosis in the developing world: recent advances in diagnosis with special consideration of extensively drug-resistant tuberculosis.
Grandjean L, Moore D
Curr Opin Infect Dis. 2008; 21(5):454-61.
PMID: 18725793
PMC: 2955353.
DOI: 10.1097/QCO.0b013e32830ce783.
Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin.
Safi H, Sayers B, Hazbon M, Alland D
Antimicrob Agents Chemother. 2008; 52(6):2027-34.
PMID: 18378710
PMC: 2415778.
DOI: 10.1128/AAC.01486-07.
Mycobacterium alsiense, a novel, slowly growing species isolated from two patients with pulmonary disease.
Richter E, Tortoli E, Fischer A, Hendricks O, Engel R, Hillemann D
J Clin Microbiol. 2007; 45(11):3837-9.
PMID: 17804654
PMC: 2168491.
DOI: 10.1128/JCM.01097-07.
In vitro antimycobacterial spectrum of a diarylquinoline ATP synthase inhibitor.
Huitric E, Verhasselt P, Andries K, Hoffner S
Antimicrob Agents Chemother. 2007; 51(11):4202-4.
PMID: 17709466
PMC: 2151410.
DOI: 10.1128/AAC.00181-07.
Drug susceptibility testing of Mycobacterium tuberculosis complex by use of a high-throughput, reproducible, absolute concentration method.
van Klingeren B, Dessens-Kroon M, van der Laan T, Kremer K, van Soolingen D
J Clin Microbiol. 2007; 45(8):2662-8.
PMID: 17537932
PMC: 1951260.
DOI: 10.1128/JCM.00244-07.
Use of the INNO LiPA Rif.TB for detection of Mycobacterium tuberculosis DNA directly in clinical specimens and for simultaneous determination of rifampin susceptibility.
Tortoli E, Marcelli F
Eur J Clin Microbiol Infect Dis. 2006; 26(1):51-5.
PMID: 17180347
DOI: 10.1007/s10096-006-0240-x.
Molecular characterisation of Mycobacterium tuberculosis isolates in the First National Survey of Anti-tuberculosis Drug Resistance from Venezuela.
Aristimuno L, Armengol R, Cebollada A, Espana M, Guilarte A, Lafoz C
BMC Microbiol. 2006; 6:90.
PMID: 17032442
PMC: 1621067.
DOI: 10.1186/1471-2180-6-90.
Evaluation of a novel kit for use with the BacT/ALERT 3D system for drug susceptibility testing of Mycobacterium tuberculosis.
Werngren J, Klintz L, Hoffner S
J Clin Microbiol. 2006; 44(6):2130-2.
PMID: 16757609
PMC: 1489433.
DOI: 10.1128/JCM.02218-05.
Rapid detection of rifampin resistance in Mycobacterium tuberculosis by Pyrosequencing technology.
Jureen P, Engstrand L, Eriksson S, Alderborn A, Krabbe M, Hoffner S
J Clin Microbiol. 2006; 44(6):1925-9.
PMID: 16757581
PMC: 1489404.
DOI: 10.1128/JCM.02210-05.
Molecular epidemiology of Mycobacterium tuberculosis in western Sweden.
Brudey K, Gordon M, Mostrom P, Svensson L, Jonsson B, Sola C
J Clin Microbiol. 2004; 42(7):3046-51.
PMID: 15243058
PMC: 446260.
DOI: 10.1128/JCM.42.7.3046-3051.2004.
Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method.
Martin A, Camacho M, Portaels F, Palomino J
Antimicrob Agents Chemother. 2003; 47(11):3616-9.
PMID: 14576129
PMC: 253784.
DOI: 10.1128/AAC.47.11.3616-3619.2003.